Effect of leaf extracts of Vernonia amygdalina on glucose utilization in chang-liver, C2C12 muscle and 3T3-L1 cells

Pharmaceutical Biology

Volumn 47, Issue 2, 2009, Pages 175-181

  Erasto, P ^a   Van De Venter, M ^a   Roux, S ^b   Grierson, D S ^a   Afolayan, A J ^b  

^a UNIVERSITY OF FORT HARE   (South Africa)

^b NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

3T3 L1; C2C12 muscle; Chang liver; Diabetes mellitus diabetes mellitus; Glucose utilization; Vernonia amygdalina

Indexed keywords

2 PROPANOL; ACETONE; GLUCOSE; HEXANE; METHANOL; VERNONIA AMYGDALINA EXTRACT; WATER;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; GLUCOSE UTILIZATION; LIVER CELL; MOUSE; MUSCLE CELL; NONHUMAN; PLANT LEAF; VERNONIA; VERNONIA AMYGDALINA;

ASTERACEAE; VERNONIA AMYGDALINA;

EID: 70749114016     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200802436927     Document Type: Article

References (17)

1. Akah PA, Ekekwe RK (1995): Ethnopharmacology of some Asteraceae family used in Nigerian traditional medicine. Fitoterapia 66: 351-355.
2. Anaga AO, Njoku CJ, Ekejiuba ES, Esiaka MN, Asuzu IU (2004): Investigation of the methanolic leaf extract of Costus afer. Ker for pharmacological activities in vivo and in vitro. Phytomedicine 11: 242-248.
3. Bailey CJ, Day C (2004): Avandamet: Combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. Int J Clin Pract 58: 867-876.
4. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI (1999): Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. New Engl J Med 341: 240-245.
5. Erasto P, Adebola PO, Grierson DS, Afolayan AJ (2005): An ethnobotanical study of the plants used for the treatment of diabetes in the Eastern Cape Province, South Africa. Afr J Biotech 4:1458-1460.
6. Erasto P, Grierson DS, Afolayan AJ (2006): Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J Ethnopharmacol 106:117-120.
7. Huffman MA, Page JE, Sukhdeo MVK, Gotoh S, Kalunde MS, Towers GHN (1996): Leaf swallowing by chimpanzees: A behavioral adaptation for the control of strong nematode infections. Int J Primatol 72: 475-503.
8. Igile GO, Oleszek W, Jurzysta M, Burda S, Fanfunso M, Fasanmade AA (1994): Flavonoids from Vernonia amygdalina and their antioxidant activities. J Agric Food Chem 42: 2445-2448.
9. Jisaka M, Ohigashi H, Irie R, Huffman MA, Nishida T, Kaji M, Koshimizu K (1992): Bitter steroidal glucosides, vernonioside A1, A2 & A3, and their related B1 from a possible medicinal plant Vernonia amygdalina, used by wild chimpanzees. Tetrahedron 48:625-632.
10. Li WL, Zheng HC, Bukuru J, De Kimpe N (2004): Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 92: 1-21.
11. Maiti R, Jana D, Das UK, Ghosh D (2004): Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin- induced diabetic rats. J Ethnopharmacol 92: 85-91.
12. Marles RJ, and Farnsworth NR (1995): Antidiabetic plants and their active constituents. Phytomedicine 2: 137-189.
13. Mosmann T (1983): Rapid colorimetric assay for cellular growth and survival: Application to prolifereation and cytotoxic assays. J Immunol Methods 65: 55-63.
14. Ohigashi H, Jisaka M, Takagaki T, Tada T, Huffman MA, Nishida T, Kaji M, Koshimizu K (1991): Bitter principle and a related steroid glucoside from Vernonia amygdalina, a possible medicinal plant for wild chimpanzees. Agric Biol Chem 55: 1201-1203.
15. Schmitz-Peiffer C, Craig DL, Biden TJ (1999): Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274: 24202-24210.
16. Uhegbu FO (2004): Effect of aqueous extract (crude) of leaves of Vernonia amygdalina (Del.) on blood glucose, serum albumin and cholesterol levels in diabetic albino rats. Global J Pure Appl Science 10: 189-194.
17. Van de Venter M, Wilson G, Roux S (2006): An optimized method to screen for in vitro antidiabetic activity. Proceedings of the Ninth International Conference on Ethnopharmacology, Nanjing, China, 22-26 August.